
Thirty-four patients with cancer zzso or ARC zzso with severe T cell zzso or imbalance zzso a long time after completion of any zzso treatment were treated by zzso 30 zzso 3 days per week during three zzso The drug has no toxicity of any zzso zzso of T cell zzso after completion of zzso therapy showed a significant improvement of the absolute number of zzso cells in peripheral zzso zzso zzso zzso initially increased or decreased were modified towards zzso but the modification reached statistical significance only in the zzso with initial absolute zzso of zzso zzso zzso ratio was significantly increased whether considering all cycles of therapy, or all those given to patients with initially high or normal zzso zzso zzso appears to have zzso properties which might be useful in cancer zzso 

